College Grub News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Improvement over existing therapies. This is based on the successful breakthrough designation created by congress back in 20 is 12. This has worked and accelerated oncology drug reviews by more than two years. In short h. R. 4374 addresses the access to the newest available products by expanding the circumstances under which emergency use authorizations can be issued and by establishing a pathway to full approval of products at the secretary of defense requests. Policies were bipartisan and developed with input from the administration and authorizing committees in the house and the senate. C. B. O. Has indicated that h. R. 4374 will have no impact on direct spending or revenue. So, mr. Speaker, this is not only a good bill but an important bill for our men and women in uniform and i urge my colleagues to support h. R. 4374. And i reserve the balance of my time. The speaker pro tempore the gentleman reserves. Today we are mr. Pallone today we are talking about authorizing emergency uses

New yorkUnited statesNew marketWest virginiaNew jerseySouth dakotaWest pointDave campKatherine clarkSaddam husseinBarbara leeLas j rineyBarack obamaGeorge w bushMac thornberryAccess medical